Peter G. Milner

1.7k total citations
28 papers, 1.4k citations indexed

About

Peter G. Milner is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Peter G. Milner has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Peter G. Milner's work include Proteoglycans and glycosaminoglycans research (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Peter G. Milner is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Peter G. Milner collaborates with scholars based in United States, Canada and Germany. Peter G. Milner's co-authors include Thomas F. Deuel, Charles Kodner, Robert I. Garver, Christine Chan, Mark A. Watson, Jeffrey Milbrandt, Anil K. Chauhan, Yuesheng Li, Helen Donis-Keller and Diane M. Radford and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Peter G. Milner

27 papers receiving 1.4k citations

Peers

Peter G. Milner
Husna Abedi United Kingdom
W G King United States
Anna Zetser Israel
Mary Shannon Byers United States
C C Reynolds United States
Evangeline V. Amargo United States
Florence A. Scholl Switzerland
Marc Delcommenne United States
Hoanh Tran United States
Claudio Raimondi United Kingdom
Husna Abedi United Kingdom
Peter G. Milner
Citations per year, relative to Peter G. Milner Peter G. Milner (= 1×) peers Husna Abedi

Countries citing papers authored by Peter G. Milner

Since Specialization
Citations

This map shows the geographic impact of Peter G. Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Milner more than expected).

Fields of papers citing papers by Peter G. Milner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Milner. The network helps show where Peter G. Milner may publish in the future.

Co-authorship network of co-authors of Peter G. Milner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter G. Milner. A scholar is included among the top collaborators of Peter G. Milner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter G. Milner. Peter G. Milner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albrecht, Detlef, et al.. (2017). Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease. Thrombosis and Haemostasis. 117(11). 2026–2033. 14 indexed citations
2.
Albrecht, Detlef, David Ellis, Daniel M. Canafax, et al.. (2017). Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant. Thrombosis and Haemostasis. 117(4). 706–717. 9 indexed citations
3.
Whitlock, Richard, Christopher B. Fordyce, Mark Midei, et al.. (2016). A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin. Thrombosis and Haemostasis. 116(8). 241–250. 7 indexed citations
4.
Ezekowitz, Michael D., Rangadham Nagarakanti, Andrzej Lubiński, et al.. (2011). A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 34(1). 1–9. 19 indexed citations
5.
Bavisotto, Linda M., David Ellis, Peter G. Milner, et al.. (2010). Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants. The Journal of Clinical Pharmacology. 51(4). 561–574. 23 indexed citations
6.
7.
Holmes, Darren L., et al.. (2000). Site Specific 1:1 Opioid:Albumin Conjugate with in Vitro Activity and Long in Vivo Duration. Bioconjugate Chemistry. 11(4). 439–444. 17 indexed citations
8.
Chronos, Nicolas A.F., Elisabeth Schieffer, Spencer J. Palmer, et al.. (1997). Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis. Catheterization and Cardiovascular Diagnosis. 41(3). 348–353. 13 indexed citations
9.
Robinson, Keith A., Nicolas A.F. Chronos, Elisabeth Schieffer, et al.. (1997). Pharmacokinetics and tissue localization of antisense oligonucleotides in balloon-injured pig coronary arteries after local delivery with an iontophoretic balloon catheter. Catheterization and Cardiovascular Diagnosis. 41(3). 354–359. 11 indexed citations
10.
Brooks, Alan R., Dov Shiffman, Christine Chan, Eric E. Brooks, & Peter G. Milner. (1996). Functional Analysis of the Human Cyclin D2 and Cyclin D3 Promoters. Journal of Biological Chemistry. 271(15). 9090–9099. 109 indexed citations
11.
Shiffman, Dov, Eric E. Brooks, Alan R. Brooks, Christine Chan, & Peter G. Milner. (1996). Characterization of the Human Cyclin-dependent Kinase 2 Gene. Journal of Biological Chemistry. 271(21). 12199–12204. 42 indexed citations
12.
Garver, Robert I., Christine Chan, & Peter G. Milner. (1993). Reciprocal Expression of Pleiotrophin and Midkine in Normal Versus Malignant Lung Tissues. American Journal of Respiratory Cell and Molecular Biology. 9(5). 463–466. 104 indexed citations
13.
Novotny, William, et al.. (1993). Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(12). 1798–1805. 27 indexed citations
14.
Milner, Peter G., et al.. (1992). Cloning, nucleotide sequence, and chromosome localization of the human pleiotrophin gene. Biochemistry. 31(48). 12023–12028. 18 indexed citations
15.
Milner, Peter G.. (1991). Simian sarcoma virus transformation of normal rat kidney fibroblasts is associated with markedly increased basic fibroblast growth factor expression. Biochemical and Biophysical Research Communications. 180(1). 423–430. 4 indexed citations
16.
Milner, Peter G., et al.. (1989). A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequence. Biochemical and Biophysical Research Communications. 165(3). 1096–1103. 195 indexed citations
17.
Milner, Peter G., Nicholas J. Izzo, J Saye, et al.. (1988). Endothelium-dependent relaxation is independent of arachidonic acid release.. Journal of Clinical Investigation. 81(6). 1795–1803. 7 indexed citations
18.
Milner, Peter G., John Dimarco, & Bruce B. Lerman. (1988). Electrophysiological Evaluation of Sustained Ventricular Tachyarrhythmias in Idiopathic Dilated Cardiomyopathy. Pacing and Clinical Electrophysiology. 11(5). 562–568. 51 indexed citations
19.
Deuel, Thomas F., et al.. (1987). Platelet-derived growth factor/sis in normal and neoplastic cell growth. Journal of Cellular Physiology. 133(S5). 95–99. 19 indexed citations
20.
Milner, Peter G., Edward V. Platia, Philip R. Reid, & Lawrence S.C. Griffith. (1985). Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. The American Journal of Cardiology. 56(10). 588–592. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Husna Abedi Breakdown of academic impact, for papers by W G King Breakdown of academic impact, for papers by Anna Zetser Breakdown of academic impact, for papers by Mary Shannon Byers Breakdown of academic impact, for papers by C C Reynolds Breakdown of academic impact, for papers by Evangeline V. Amargo Breakdown of academic impact, for papers by Florence A. Scholl Breakdown of academic impact, for papers by Marc Delcommenne Breakdown of academic impact, for papers by Hoanh Tran Breakdown of academic impact, for papers by Claudio Raimondi
Rankless by CCL
2026